Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Lysine-arginine imbalance overcomes therapeutic tolerance governed by the transcription factor E3-lysosome axis in glioblastoma

ABSTRACT: Lysine-arginine imbalance overcomes therapeutic tolerance governed by the transcription factor E3-lysosome axis in glioblastoma

PROVIDER: PRJNA962675 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR24330249_1.fastq.gz	Fastqsanger.gz
	SRR24330249_2.fastq.gz	Fastqsanger.gz
	SRR24330250_1.fastq.gz	Fastqsanger.gz
	SRR24330250_2.fastq.gz	Fastqsanger.gz
	SRR24330251_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 32

Similar Datasets

Lysine-arginine imbalance overcomes therapeutic tolerance governed by the transcription factor E3-lysosome axis in glioblastoma

Project description:This SuperSeries is composed of the SubSeries listed below.

2024-12-11 | GSE230826 | GEO

Oligodendrocyte precursor cells facilitate neuronal lysosome release

Project description:Oligodendrocyte precursor cells (OPCs) shape brain function through complex mechanisms. We found that OPCs facilitate neuronal lysosome exocytosis by contacting neuronal somata. Reduced number or process branching of OPCs decreased these contacts, accompanied with lysosome accumulation and altered metabolism in neurons, and more senescent neurons with age. In Alzheimer's mouse models, OPC-neuron contacts were fewer, and lysosomes accumulated. Our findings are relevant for preventing aging-related pathologies and treatment of neurodegenerative diseases.

2025-01-14 | GSE285995 | GEO

Mycobacterium tuberculosis resides in lysosome-poor monocyte-derived lung cells during chronic infection

Project description:Mycobacterium tuberculosis (Mtb) infects multiple lung myeloid cell subsets and persists despite innate and adaptive immune responses. However, the mechanisms allowing Mtb to evade elimination by these subsets are not fully understood. Here, we determined that four weeks post infection, after development of adaptive immune responses, CD11clo monocyte-derived lung cells termed MNC1 (mononuclear cell subset 1), harbor more live Mtb compared to alveolar macrophages (AM), neutrophils, and less permissive CD11chi MNC2. Bulk RNA-seq analysis for these subsets identified that lysosome biogenesis pathway is underexpressed in MNC1. Functional assays confirmed that Mtb-permissive MNC1 are deficient in lysosome content, lysosomal acidification, and lysosomal activity compared to AM, and have less nuclear TFEB, a master regulator of lysosome biogenesis. Mtb infection does not alter lysosome deficiency in MNC1. Instead, Mtb recruits MNC1 and MNC2 to the lungs for its spread from AM to these subsets, which depend on Mtb ESX-1 secretion system. Furthermore, nilotinib-mediated TFEB activation enhances lysosome function of primary macrophages in vitro, and MNC1 and MNC2 in vivo, improving control of Mtb infection. Our results suggest that Mtb exploits lysosome-poor monocyte-derived lung cells for persistence; targeting lysosome biogenesis may be an effective approach to host-directed therapy for tuberculosis, enabling permissive lung cells to restrict and kill Mtb through autophagy and other mechanisms.

2023-02-08 | GSE220147 | GEO

Lysosome activity-dependent changes of gene expression in BMDM after LPS treatment

Project description:We report changes of gene expression in lysosome-inhibited BMDM after LPS treatment.

2024-04-06 | GSE181642 | GEO

HIF1a inhibition overcomes castration resistance

Project description:HIF1a inhibition overcomes castration resistance

| PRJNA892463 | ENA

Oligodendrocyte precursor cells facilitate neuronal lysosome release

Project description:Oligodendrocyte precursor cells facilitate neuronal lysosome release

| PRJNA1207448 | ENA

CCDC50 promotes tumor growth through regulation of lysosome homeostasis

Project description:Cutaneous melanoma is characterized by lineage-specific lysosome-associated vesicular trafficking. Specifically, we report a melanoma enrichened lysophagy receptor, CCDC50, controlling lysosomal homeostasis and autolysosomal activity. We reveal that targeting CCDC50 in melanoma may be a promising therapeutic strategy, as nearly 70% of human melanomas highly express CCDC50. Moreover, targeting CCDC50 together with BRAFV600E inhibition induces synergistic function in regression of melanoma tumors, representing an alternative strategy for melanoma therapy. We performed transcriptome profiling (RNA-seq) and quantitative reverse transcription polymerase chain reaction (qRT–PCR) in shCtrl and shCCDC50 cells to evaluate the melanoma growth and metastasis controlled by CCDC50. The deep sequencing results showed that CCDC50 defciency caused increased lysosome and vacuolar memebrane and blocked autophagy flux.

2021-12-06 | GSE190144 | GEO

Allelic imbalance is a prevalent and tissue-specific feature of the mouse transcriptome

Project description:We perform a systematic classification of allelic imbalance in mouse hybrids derived from reciprocal crosses of divergent strains. We observe that deviation from balanced biallelic expression is common, occurring in ~20% of the mouse transcriptome. Allelic imbalance attributed to genotype is by far the most prevalent class and typically is tissue-specific. However, some genotype-based imbalance is maintained across tissues and is associated with greater genetic variation, especially in 5’ and 3’ termini of transcripts. We further identify novel random monoallelic and imprinted genes, and find that genotype can compete with parental origin even in the setting of large imprinted regions. PolyA-selected RNA-sequencing in F1 hybrid and parental cells of Mm. musculus and Mm. castaneus origin

2015-05-28 | E-GEOD-58524 | biostudies-arrayexpress

Dynamic allelic imbalance in early mouse embryo

Project description:We used a reciprocal crosses model to assess the allelic imbalance in early mouse embryo

2019-11-05 | GSE127106 | GEO

Redox Imbalance in COVID-19 Pathophysiology

Project description:Redox Imbalance in COVID-19 Pathophysiology

| PRJNA873078 | ENA